Suomen sivusto, jossa voit ostaa halvalla ja laadukas Viagra http://osta-apteekki.com/ toimitus kaikkialle maailmaan.

Erityisesti laatu viagra tästä kaupasta voi taata henkilökohtaisesti viagra Paras laatu kehotan Teitä miellyttää.

Hlbbshaw.co.uk2

Dr Mathew Leese: Publications, Patents & Conferences - 1997-2012

Publications
Steroidomimetic tetrahydroisoquinolines for the design of new microtubule disruptors. Leese, M. P.; Jourdan, F.; Dohle, W.; Kimberley, M. R.; Thomas, M. P.; Bai, R.; Hamel, E.; Ferrandis, E.; Potter, B. V. L. ACS MedChemLett 2012, 3, 5-9.
Structure-Activity Relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer Jourdan, F.; Leese, M. P.; Dohle, W.; Ferrandis, E.; Newman, S. P.; Chander, S.; Purohit, A.; Potter, B. V. L. J. Med. Chem. 2011, 54, 4863-4879.
Discovery of chimeric microtubule disruptors. Leese, M.P.; Jourdan, F.; Kimberley, M.R.; Cozier, G.E.; Thiyagarajan, N.; Stengel, C.; Regis-Lydi, S.;, Foster, P.A.; Newman, S.P.; Acharya, K.R.; Ferrandis, E.; Purohit, A.; Reed, M.J.; Potter, B.V.L. Chem Commun 2010, 46, 2907. Cover article 7th May 2010, selected for RSC highlights in Chemical Biology. Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. Cozier, G.; Leese, M.P.; Lloyd, M.; Baker, M.; Thiyagarajan, N.; Acharya, K.R.; Potter, B.V.L. Biochemistry 2010, 49, 3464-3476. Synthesis, Antitubulin and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17- O,O-bissulfamate. Jourdan, F.; Leese, M.P; Dohle, W; Hamel, E.; Ferrandis, E.; Newman, S.P.; Purohit A.; Reed, M.J.; Potter, B.V.L. J Med Chem 2010, 53, 2942-51. -tubulin expression and in vitro resistance to microtubule targeting agents Stengel, C.; Newman, S.P.; Leese, M.P.; Potter, M.P.; Reed, M.J.; Purohit, A. Br J Cancer 2010, 102, 316-324. STX140 and STX641 Cause Apoptosis via the Intrinsic Mitochondrial Pathway and Down- regulate Survivin and XIAP Expression in Ovarian and Prostate Cancer Cells. Foster, P. A.; Ho, Y. T.; Newman, S. P.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A. Anticancer Research 2009, 29
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. Day, J. M.; Foster, P. A.; Tutil , H. J.; Newman, S. P.; Ho, Y. T.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A. Br J A new micronized formulation of 2-methoxyestradiolbis-sulfamate (STX140) is therapeutical y potent against breast cancer. Foster, P. A.; Newman, S. P.; Leese, M. P.; Bernetiere, S.; Diolez, C.; Camara, J.; Hacher, B.; Baronnet, M. M.; Ali, T.; Potter, B. V. L.; Reed, M. J.; Purohit, A. Anticancer A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140. Foster, P. A.; Stengel, C.; Ali, T.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Newman, S. P. Anticancer Res 2008, 28, 1483-1491. The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer. Parsons, M. F. C.; Foster, P. A.; Chander, S. K.; Jhal i, R.; Newman, S. P.; Leese, M. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J. Br J Cancer 2008, 99, 1433-1441. 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer. Tagg, S. L. C.; Foster, P. A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Newman, S. P. Br J Cancer 2008, 99, 1842-1848. Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)- triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modeling. Jourdan, F.; Bubert, C.; Leese, M. P.; Smith, A.; Ferrandis, E.; Regis-Lydi, S.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Org Biomol Chem 2008, 6, 4108-4119. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cel cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Foster, P. A.; Ho, Y. T.; Raobaikady, B.; Newman, S. P.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed M. J.; Purohit, A. Breast Cancer STX140, is efficacious in vitro and in vivo in taxane resistant breast carcinoma cells. Newman, S. P.; Foster, P. A.; Stengel, C.; Day, J.M.; Ho, Y.T.; Judde, J.-G.; Lassal e, M.; Prevost, G.; Leese, M. P.; Potter, B. V. L.; Reed M. J.;Purohit, A. Clin Cancer Res 2008, 14, 597-606. Structure-activity relationships of C-17 cyanated estratrienes as anti-cancer agents. Leese M. P.; Jourdan F. L.; Gaukroger, K.; Mahon, M. F.; Newman, S. P.; Foster, P. A.; Stengel, C.; Regis-Lydi, S.; Ferrandis, E.; Di Fiore, A.; De Simone, G.; Supuran, C. T.; Purohit, A.; Reed M. J.; Potter, B. V. L. The therapeutic potential of a series of oral y bioavailable antiangiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers. Newman, S. P.; Foster, P. A.; Ho, Y. T.; Day, J. M.; Raobaikady, B.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A. Br J Cancer 2007, 97, 1673-1682. 3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol derivatives: Synthesis, in vitro and in vivo anticancer activity. Bubert, C.; Leese, M. P.; Mahon, M. F.; Ferrandis, E.; Regis-Lydi, S.; Kasprzyk, P. G.; Newman, S. P.; Ho, Y. T.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J Med Chem 2007, 50, 4431- In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. Chander, S. K.; Foster, P. A.; Leese, M. P.; Newman, S. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J. 2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity. Leese, M. P.; Leblond, B.; Smith, A.; Newman, S. P.; Di Fiore, A.; De Simone, G.; Supuran, C. T.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J Med Chem -hydroxysteroid dehydrogenases in modulating the activity of 2- methoxyestradiol in breast cancer cells. Newman, S. P.; Ireson, C. R.; Tutil , H. J.; Day, J. M.; Parsons, M. F. C.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A. Cancer Res 2006, 66, 324- Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.Raobaikady, B.; Reed, M. J.; Leese, M. P.; Potter, B. V. L.; Purohit, A. Int J Cancer 2005, 117, 150-159. A-Ring-substituted estrogen-3-O-sulfamates: Potent multitargeted anticancer agents. Leese, M. P.; Hejaz, H. A. M.; Mahon, M. F.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J Med Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues. Purohit, A.; Ghilchik, M. W.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2005, 94, 167-172. The effects of 2-methoxyoestrogen sulpharnates on the in vitro and in vivo proliferation of breast cancer cel s. Utsumi, T.; Leese, M. P.; Chander, S. K.; Gaukroger, K.; Purohit, A.; Newman, S. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2005, 94, 219-227. Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates. Leese, M. P.; Leblond, B.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L. J Steroid Biochem Mol 2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents. Leese, M. P.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Bioorg Med Chem Lett 2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases. Wood, L.; Leese, M. P.; Mouzakiti, A.; Purohit, A.; Potter, B. V. L.; Reed, M. J.; Packham, G. Apoptosis 2004, 9, 323-332. 2-Difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor. Reed, J. E.; Woo, L. W. L.; Robinson, J. J.; Leblond, B.; Leese, M. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Biochem Biophys Res Comm 2004, 317, 169-175. Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates. Newman, S. P.; Leese, M. P.; Purohit, A.; James, D. R. C.; Rennie, C. E.; Potter, B. V. L.; Reed, M. J. Int J Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis- sulphamate in vivo in rodents. Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J. Br J Cancer 2004, 90, 932-937. Steroid sulphatase inhibitors for breast cancer therapy. Purohit, A.; Woo, L. W. L.; Chander, S. K.; Newman, S. P.; Ireson, C.; Ho, Y.; Grasso, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2003, 86, 423-432. The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-alpha on endothelial and fibroblast cel growth, morphology and apoptosis.Ho, Y. T.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2003, 86, 189- Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates. Ho, Y. T.; Purohit, A.; Vicker, N.; Newman, S. P.; Robinson, J. J.; Leese, M. P.; Ganeshapil ai, D.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J. Biochem Biophys Res Comm 2003, 305, 909-914. Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis- sulphamate and 2-ethyloestradiol-bis-sulphamate.Suzuki, R. N.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2003, 84, 269-278. The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells. Day, J. M.; Newman, S. P.; Comninos, A.; Solomon, C.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2003, 84, 317-325. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2- methoxyoestradiol-bis-sulphamate. Raobaikady, B.; Purohit, A.; Chander, S. K.; Woo, L. W. L.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. J Steroid Biochem Mol Biol 2003, 84, 351-358. Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships. Wood, L.; Leese, M. P.; Leblond, B.; Woo, L. W. L.; Ganeshapil ai, D.; Purohit, A.; Reed, M. J.; Potter, B. V. L.; Packham, G. Anti-Cancer Drug Des 2001, A survey of suitable protecting groups for the synthesis of hydroxylamines by Mitsunobu reactions. Knight, D. W.; Leese, M. P. Tetrahedron Lett 2001, 42, 2593-2595. The synthesis of N-hydroxyisoindolines by reverse-Cope chemistry. Knight, D. W.; Leese, M. P.; De Kimpe, N. Tetrahedron Lett 2001, 42, 2597-2600. Palladium catalysed coupling reactions using guanidinium phosphine complexes on glass beads. Leese, M. P.; Wil iams, J. M. J. Synlett 1999, 1645-1647. Transition metal catalysed reactions using glass bead technology.Anson, M. S.; Leese, M. P.; Tonks, L.; Wil iams, J. M. J. J Chem Soc Dalton Trans 1998, 3529-3538. Optimisation of palladium-based supported liquid-phase catalysts in the Heck reaction.Mirza, A. R.; Anson, M. S.; Hel gardt, K.; Leese, M. P.; Thompson, D. F.; Tonks, L.; Wil iams, J. M. J. Org Al ene formation by the reaction of olefins with propargyl silyl ethers mediated by a zirconocene complex. Takahashi, T.; Hara, R.; Huo, S. Q.; Ura, Y.; Leese, M. P.; Suzuki, N. Tetrahedron Lett 1997, 38, 8723-8726. A new, stereoselective, approach to pyrrolidine-N-oxides by sequential condensation of sulfones with nitrones and reverse-Cope elimination. Wheildon, A. R.; Knight, D. W.; Leese, M. P. Tetrahedron Lett 1997, 38, 8553-8556.
WO 2008/117061: Compound
US 20070225256: 2-Substituted estrogen sulphamates for inhibition of steroid sulphatase
US 20060094696: Oestrogen derivatives for inhibition of steroid sulphatase
US 7,119,081: Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
US 7,067,503: 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
Conference Presentations
February 2011: Comprehensive Approach to Cancer and Infectious Disease, Okayama, Japan (Invited lecture). November 2010: AACR NCI EORTC Molecular Targets and Cancer Therapeutics Meeting, Berlin, Germany (Poster). April 2009: AACR Annual Meeting, Denver CO (Poster). April 2008: AACR Annual Meeting, San Diego, CA (Oral). November 2007: AACR NCI EORTC Molecular Targets and Cancer Therapeutics Meeting, San Francisco, CA (Poster). September 2006: XVth European Conference of the GP2A, Bath, UK (Oral). April 2006: AACR Annual Meeting, Washington DC (Poster). November 2005: AACR NCI EORTC Molecular Targets and Cancer Therapeutics Meeting, Philadelphia, PA (Poster). September 2004: AACR NCI EORTC Molecular Targets and Cancer Therapeutics Meeting, Geneva, January 2002: Novabiochem Parallel Synthesis Meeting, Basel, Switzerland. August 2000: ACS Fal National Meeting, Washington, DC (Poster). June 1997: RSC Heterocyclic Group Symposium, Keele, UK (Oral). April 1997: ACS Spring National Meeting, San Francisco, CA (Poster).

Source: http://www.hlbbshaw.co.uk/assets/pdf/mlpubs.pdf

Kumar_ejgh_2007

Tumour M2-pyruvate kinase: a gastrointestinal cancer markerYogesh Kumar, Niteen Tapuria, Naveed Kirmani and Brian R. DavidsonBackground Gastrointestinal cancer tumour markers areethylenediaminetetraacetic acid (EDTA) plasma tumourvaluable in the detection of recurrence following resectionM2-pyruvate kinase were analysed together as a smallor in monitoring response to chemotherapy. CEA, CA19-9

Mifidcesr1stmand2ndconsresponsefinal.pdf

International Swaps and Derivatives Association International Securities Market Association International Primary Market Association Association of Norwegian Stockbroking Companies Bankers and Securities Dealers Association of Iceland Bond Market Association Danish Securities Dealers Association Finnish Association of Securities Dealers Futures and Options Associat

Copyright © 2010-2014 Medical Pdf Articles